Audited by PwC

Income statement - the Novozymes Group

Note 2012 2011
            DKK million DKK million  
1, 2 Revenue 11,234  10,510 
3, 6 Cost of goods sold 4,811  4,602 
  Gross profit   6,423  5,908   
   
3, 6 Sales and distribution costs 1,421  1,376 
3, 6 Research and development costs 1,527  1,464 
3, 4, 5, 6 Administrative costs 808  778 
7 Other operating income, net 78  50 
Operating profit / EBIT   2,745  2,340   
8 Financial income 22  208 
9 Financial costs 183  133 
Profit before tax   2,584  2,415   
10 Tax 568  587 
  Net profit   2,016  1,828   
Attributable to
Shareholders in Novozymes A/S 2,015  1,826 
Minority interests    
2,016  1,828 
Proposed dividend per share DKK 2.20 DKK 1.90
19 Earnings per share DKK 6.42 DKK 5.79
19 Earnings per share, diluted DKK 6.33 DKK 5.71
To the top